Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
iSpecimen ( (ISPC) ) has provided an update.
On June 18, 2025, Richard J. Paolone and John L. Brooks III resigned from the Board of Directors of iSpecimen Inc., with no disagreements cited regarding company operations or policies. Subsequently, on June 20, 2025, Anthony Lau was appointed to the Board, bringing extensive experience in corporate governance and financial oversight, which is expected to enhance the company’s governance and oversight capabilities.
Spark’s Take on ISPC Stock
According to Spark, TipRanks’ AI Analyst, ISPC is a Underperform.
The overall stock score is primarily impacted by poor financial performance, negative valuation metrics, and technical analysis indicating bearish trends. The additional risk of Nasdaq non-compliance raises concerns about the company’s stability and future trading prospects.
To see Spark’s full report on ISPC stock, click here.
More about iSpecimen
Average Trading Volume: 78,418
Technical Sentiment Signal: Sell
Current Market Cap: $2.4M
See more data about ISPC stock on TipRanks’ Stock Analysis page.